Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

This is a first in human (FIH), Phase 1 dose escalation and expansion study in select solid tumors. This study includes 2 parts: a Dose Escalation and Backfill portion (Part A) and a Dose Expansion portion (Part B).

Participants needed: 155
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: NEOK Bio, Inc.Updated: Jun 1, 2026Locations: 8
Eligibility criteria

Participants must have locally advanced or metatstatic disease in a select tumor... [+4]

Participant's most recent systemic anti-cancer treatment was an ADC with a topoi... [+4]

Status: Recruiting

A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

This is a first in human (FIH), Phase 1, dose escalation and expansion study in select solid tumors. This study includes 2 parts: a Dose Escalation and Backfill portion (Part A) and a Dose Expansion portion (Part B).

Participants needed: 155
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: NEOK Bio, Inc.Updated: May 28, 2026Locations: 8
Eligibility criteria

Participants must have locally advanced or metastatic disease in a select tumor... [+4]

Participant's most recent systemic anti-cancer treatment was an ADC with a topoi... [+4]